Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

NCT06787014 · clinicaltrials.gov ↗

RECRUITING

Status

3200

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine (NE) Tumors
Metastasis
Bowel Obstruction

Interventions

OTHER: Histopathological review

Sponsor

Insel Gruppe AG, University Hospital Bern